New adaptable nanoparticle platform enables enhanced delivery of gene therapies, RCSI research
New adaptable nanoparticle platform enables enhanced delivery of gene therapies, RCSI research DULBIN, June 9, 2021 /PRNewswire/ -- Scientists have developed polypeptide-based materials that act as effective vectors for delivering gene therapies. The first-of-its-kind platform enables the vectors to be adapted to suit the specific gene therapy cargo. The work, led by researchers from RCSI University of Medicine and Health Sciences and funded by Science Foundation Ireland, is published in Biomaterials Science. A major challenge for gene therapies is preparing them in a way that can deliver t...